14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー Chronic inflammatory demyelinating polyneuropathy Clinical trials / Disease details

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

21 trials found

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-003448-28-PL (EUCTR)	07/07/2015	06/05/2015	Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobu ...	Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 19.0;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	350	Phase 3	United States;Estonia;Finland;Spain;Lithuania;Austria;Israel;United Kingdom;Italy;France;Czech Repub ...
2	EUCTR2011-003448-28-EE (EUCTR)	11/06/2015	14/05/2015	Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobu ...	Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	350	Phase 3	United States;Estonia;Finland;Spain;Lithuania;Austria;Israel;Italy;United Kingdom;Czech Republic;Eur ...
3	EUCTR2011-003448-28-LT (EUCTR)	09/06/2015	21/04/2015	Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobu ...	Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.0;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	350	Phase 3	United States;Estonia;Finland;Spain;Lithuania;Austria;Israel;Italy;United Kingdom;Czech Republic;Eur ...
4	EUCTR2013-004157-24-CZ (EUCTR)	12/03/2015	24/03/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate thelong-term safety and efficacy of IgPro20in ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.0;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 3	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Netherlands;Germany;Italy ...
5	EUCTR2013-004157-24-NL (EUCTR)	02/12/2014	20/03/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate thelong-term safety and efficacy of IgPro20in ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 3	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Germany;Netherlands;Italy ...
6	EUCTR2013-004157-24-IT (EUCTR)	01/10/2014	21/02/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate thelong-term safety and efficacy of IgPro20in ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 16.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	70	Phase 3	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Israel;Netherlands;German ...
7	NCT02027701 (ClinicalTrials.gov)	July 30, 2014	3/1/2014	Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Infl ...	Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20i ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP);Polyradiculoneuropathy, Chronic Inflammator ...	Biological: IgPro20	CSL Behring	NULL	Completed	18 Years	N/A	All	82	Phase 3	United States;Australia;Canada;Czechia;France;Germany;Italy;Japan;Netherlands;Spain;United Kingdom;C ...
8	EUCTR2013-004157-24-DE (EUCTR)	05/06/2014	25/02/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate thelong-term safety and efficacy of IgPro20in ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 19.0;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 3	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Netherlands;Germany;Italy ...
9	EUCTR2013-004157-24-GB (EUCTR)	30/04/2014	18/02/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate the long-term safety and efficacy of IgPro20i ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	80	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Netherlands;Germany;Italy ...
10	EUCTR2013-004157-24-ES (EUCTR)	23/04/2014	27/02/2014	Extension study of maintenance treatment with subcutaneous immunoglobulin (IgPro20) for chronic infl ...	Multicenter, open-label extension study to investigate thelong-term safety and efficacy of IgPro20in ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 16.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	70	Phase 3	United States;Czech Republic;European Union;Canada;Finland;Spain;Australia;Israel;Netherlands;German ...

First Previous1 2 3Next Last